Articles tagged "Kidney transplantation"

2019 American Transplant Congress
Prolonged Fluoroquinolone Prophylaxis to Prevent BK Viremia in Kidney Transplant Recipients
S. A. Muhsin¹, S. J. Ripley², M. L. Jacobs³, K. Safa¹, D. M. Wojciechowski¹
¹Nephrology Division, MGH, Boston, MA, ²Cancer Center, MGH, Boston, MA, ³Wake Forest University School of Medicine, Winston-Salem, NC
*Purpose: Prophylaxis for kidney transplant recipients has successfully lowered early incidence of infections such as CMV. However, there are no approved agents for the prevention…
2019 American Transplant Congress
The Dry Weight Revealed!, What Transplanted Kidneys Teach Us about the (Dry Weight).
M. Hamid¹, S. Oyewolle-Eletu², G. Gudleski², K. Speta³, J. Kumar¹, S. Chang¹
¹Nephrology-Transplant, State University of New York at Buffalo (SUNY) Buffalo, Buffalo, NY, ²Jacob's School of Medicine, State University of New York at Buffalo (SUNY) Buffalo, Buffalo, NY, ³Nephrology-Transplant, Erie County Medical Center, Buffalo, NY
*Purpose: Volume overload in patients with ESRD/CKD V patients is associated with worse operative outcomes and potentially higher rate of delayed graft function, in addition…
2019 American Transplant Congress
Use of Eculizumab for Active Antibody-Mediated Rejection That Occurs Early Post-Kidney Transplantation: A Consecutive Series of 15 Cases
E. Tan¹, B. J. Andrew², P. G. Dean², M. F. Shaheen¹, M. D. Stegall², C. A. Schinstock²
¹Division of Transplantation Surgery, Mayo Clinic Rochester, Rochester, MN, ²The William J von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic Rochester, Rochester, MN
*Purpose: Active antibody-mediated rejection (ABMR) that occurs during the amnestic response within the first month post-transplant is a rare but devastating cause of early allograft…
2019 American Transplant Congress
Barriers to Listing for Kidney Transplantation in LMICs: A Single Center Retrospective Cohort Study in Brazil
Y. Yu¹, G. Ferreira², A. Saha¹, M. Henderson¹, D. Segev¹, J. Bastos², V. Colares², A. Massie¹
¹Department of Surgery, Johns Hopkins School of Medicine, Baltimore, MD, ²Santa Casa de Misericordia de Juiz de Fora, Juiz de Fora, Brazil
*Purpose: Incidence of end-stage renal disease (ESRD) is increasing in low- and middle-income countries (LMICs), but citizens of LMICs face barriers to transplantation that are…
2019 American Transplant Congress
Hepatitis A Hospitalizations among Kidney Transplant Recipients in the United States: A Nationwide Study
W. Cheungpasitporn¹, C. Thongprayoon², P. Ungprasert³, K. Wijarnpreecha⁴, P. T. Kroner⁴
¹Nephrology, University of Mississippi Medical Center, Jackson, MS, ²Nephrology and Hypertension, Mayo Clinic, Rochester, MN, ³Nephrology, University of Mississippi Medical Center, Bangkok, Thailand, ⁴Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL
*Purpose: Hepatitis A illness severity increases in immunosuppressed patients and one of important indicators of hepatitis A illness severity is whether patients require hospitalization. This…
2019 American Transplant Congress
Characteristics And Outcomes Of Early Onset Cancers After Kidney Transplantation
W. Lim¹, E. Au², A. Krishnan¹, G. Wong²
¹Sir Charles Gairdner Hospital, Perth, Australia, ²University of Sydney & Westmead Hospital, Sydney, Australia
*Purpose: Incident cancers developing after kidney transplantation are associated with significant morbidity and mortality and therefore age-appropriate cancer screening is recommended to identify asymptomatic cancers…
2019 American Transplant Congress
Full and Sustained Donor Hematopoietic Chimerism after an Isolated Kidney Transplantation
J. Zuber¹, O. Boyer¹, B. Neven¹, E. Six², R. Berthaud¹, M. Ould Rabah¹, S. Sobrino², C. Lagresle², I. André-Schmutz², M. Cavazzana¹, S. Blanche¹, R. Salomon¹
¹Paris Descartes University, Paris, France, ²Inserm UMRS 1163, Paris, France
*Purpose: Full donor chimerism was reported three times in the absence of myelosuppressive regimen, only after liver or multivisceral transplantation, but never after kidney transplantation.…
2019 American Transplant Congress
Impact of Glomerulitis at 4-Month Biopsy on Long Term Kidney Allograft Outcomes
M. Whigham, G. Mour, M. Buras, S. Sukumaran Nair, A. Jaramillo, D. Ramon, R. Heilman
Mayo Clinic, Phoenix, AZ
*Purpose: Antibody mediated rejection (AMR) is diagnosed based on combination of elevated creatinine, histopathological findings defined as glomerulitis (g), and peritubular capillaritis (ptc), with or…
2019 American Transplant Congress
Long-Term Outcomes of Eculizumab-Treated Positive Crossmatch Recipients: Allograft Survival, Histologic Findings, and Natural History of the Donor-Specific Antibodies
C. Schinstock, A. Bentall, S. Byron, L. Cornell, M. Everly, M. Gandhi, M. Stegall
Mayo Clinic, Rochester, MN
*Purpose: We aimed to determine long-term outcomes for eculizumab-treated, positive crossmatch (+XM) kidney transplant recipients as compared with +XM and age-matched negative crossmatch (−XM) control…
2019 American Transplant Congress
Persistent Mixed Chimerism, Immune Reconstitution, and Tolerance in Recipients of HLA Matched Kidney and Hematopoietic Cell Transplants
S. Busque, J. Scandling, R. Lowsky, J. Shizuru, E. Meyer, K. Jensen, A. Shori, R. Hoppe, E. Engleman, T. Pham, S. Strober
Stanford University School of Medicine, Stanford, CA
*Purpose: We evaluated the immune reconstitution of recipients of HLA matched combined kidney and hematopoietic cell transplants after tolerance induction*Methods: Twenty nine recipients of living…